Emil Kuriakose is Chief Medical Officer at Terns Pharmaceuticals, Inc. (TERN). They have made 6 open-market trades across 1 company since 2025, most recently 2026-04-01.
CIK 0001892413
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TERN | 105,673 | $5.6M |
| CALA | 3,539 | $12K |
| Total | $5.6M |
Shares reported on the most recent Form 4, priced at the 2026-04-02 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TERN | SELL | 2026-04-01 | 2026-04-02 | $52.75 | $50K | -0.0% | +0.5% | N/A |
| TERN | SELL | 2026-01-02 | 2026-01-06 | $38.57 | $45K | -3.4% | -6.7% | +39.3% |
| TERN | SELL | 2025-10-01 | 2025-10-02 | $7.85 | $7K | +0.9% | +75.2% | +404.4% |
| TERN | SELL | 2025-07-01 | 2025-07-03 | $4.27 | $4K | +22.6% | +33.7% | +81.6% |
| TERN | SELL | 2025-04-01 | 2025-04-02 | $2.49 | $2K | -2.9% | +47.1% | +61.8% |
| TERN | SELL | 2025-01-02 | 2025-01-06 | $5.71 | $26K | -22.4% | -18.4% | -65.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.